Isleworth Healthcare Acquisition ^{Priced, Nasdaq: ISLE}

We are a blank check company formed under the laws of the State of Delaware on December 15, 2020. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America, Europe and Asia that are developing assets in the biopharmaceutical and, medical technology/medical device space, which aligns with our management team’s experience in operating healthcare companies and in drug and device/technology development. At the time of preparing this prospectus, we have not identified any specific business combination, nor has anyone on our behalf initiated or engaged in any substantive discussions, formal or otherwise, related to such a transaction. Our efforts to date are limited to organizational activities related to this offering.